Medical technology company MED-EL announced Thursday that the US Food and Drug Administration has approved expanding the use of its Synchrony cochlear implants to children as young as 7 months who ...
An FDA study in two groups of children shows that MED-EL cochlear implants are safe and effective for children seven-71 months old with bilateral SNHL who cannot hear well enough with hearing aids.
Imagine a world where silence is all you know, and then, suddenly, sound bursts into your life, connecting you to loved ones ...
ST. PAUL, Minn., May 13, 2025 /PRNewswire/ -- iotaMotion, Inc., a leader in robotic-assisted systems for cochlear implant surgery, today announced the first use of the iotaSOFT® Insertion System ...
Medical Device Network on MSN
MED-EL’s cochlear implants secure expanded approval in infants
MED-EL’s cochlear implants are now FDA-approved in children seven months and older with bilateral sensorineural hearing loss (SNHL).
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Ray Cathey is on a journey from silence to new sounds. Cathey's hearing took a pounding when he was an air rescue paramedic ...
VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics (AB), a global leader in cochlear implant technology, received Health Canada approval and announces it is bringing Marvel hearing technology to ...
VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics (AB), a global leader in cochlear implant technology, in collaboration with Phonak, a leading provider of life-changing hearing solutions, receives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback